CIT Serves as Lead Arranger of $135.6MM Financing for Superior Biologics
CIT’s healthcare finance division served as lead arranger of $135.6 million in financing for Superior Biologics.
December 2, 2022
CIT | David Gibbs | Ray Mirra | Superior Biologics | William Douglass
Ian Koplin